TWD
ORKA

True Wealth Design’s Oruka Therapeutics ORKA Stock Holding History

True Wealth Design’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-26
Closed -$1.28K – 2922
2026
Q1 		$1.28K Hold
26
– – ﹤0.01% 1715
2025
Q4 		$789 Hold
26
– – ﹤0.01% 1794
2025
Q3 		$500 Buy
+26
New +$385 ﹤0.01% 2006

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

True Wealth Design's ORKA Position: Q2 2026 in Review

True Wealth Design sold out of Oruka Therapeutics (ORKA) in Q2 2026, closing a stake of 26 shares — an estimated $1.28K sold.

True Wealth Design first reported a position in ORKA in Q3 2025 and held it in 3 quarters. The position peaked at $1.28K in Q1 2026. 256 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • True Wealth Design reported no remaining Oruka Therapeutics position as of Q2 2026 after selling out during the quarter.
  • True Wealth Design sold 26 Oruka Therapeutics shares in Q2 2026, an estimated $1.28K.
  • True Wealth Design first reported a position in Oruka Therapeutics in Q3 2025 and held it in 3 quarters.
  • True Wealth Design's Oruka Therapeutics position peaked at $1.28K in Q1 2026.
  • 256 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.